ethinyl estradiol has been researched along with fosfestrol in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuse, H; Ito, H; Ki, JS; Matsuzaki, O; Sumiya, H; Yamaguchi, K | 1 |
| Akakura, K; Igarashi, T; Isaka, S; Murakami, S; Shimazaki, J; Teshima, S | 1 |
| Fiedler, R; Klebingat, KJ; Lorenz, G; Panzig, E; Steinhauser, I | 1 |
| Dörner, G; Rohde, W; Schnorr, D; Stahl, F | 1 |
| Schott, H; Zade, W | 1 |
1 trial(s) available for ethinyl estradiol and fosfestrol
| Article | Year |
|---|---|
[Cellular immunity in prostatic cancer modified by Cytonal, Estrazyt and Turisteron].
Topics: Aged; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Diethylstilbestrol; Estramustine; Ethinyl Estradiol; Humans; Immunity, Cellular; Macrophages; Male; Middle Aged; Nitrogen Mustard Compounds; Prostatic Neoplasms; Random Allocation | 1987 |
4 other study(ies) available for ethinyl estradiol and fosfestrol
| Article | Year |
|---|---|
Androphilic protein studied histochemically in stage D2 prostatic cancer.
Topics: Androgen-Binding Protein; Biopsy, Needle; Combined Modality Therapy; Diethylstilbestrol; Ethinyl Estradiol; Fluorescence; Histocytochemistry; Humans; Ligands; Male; Neoplasm Proteins; Neoplasm Staging; Orchiectomy; Prostate; Prostatic Neoplasms; Protein Binding; Staining and Labeling | 1988 |
Histological effects of endocrine therapy for prostatic cancer in relation to clinical course.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cell Nucleus; Cytoplasm; Diethylstilbestrol; Ethinyl Estradiol; Fibrosis; Hexestrol; Humans; Male; Metaplasia; Middle Aged; Necrosis; Orchiectomy; Prognosis; Prostatic Neoplasms | 1989 |
[Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Delayed-Action Preparations; Diethylstilbestrol; Ethinyl Estradiol; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testosterone | 1987 |
[Liver damage in hormone therapy of prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Diethylstilbestrol; Ethinyl Estradiol; Humans; Liver Function Tests; Male; Middle Aged; Prostatic Neoplasms | 1987 |